Viewing Study NCT00110851


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-22 @ 9:37 AM
Study NCT ID: NCT00110851
Status: COMPLETED
Last Update Posted: 2007-08-23
First Post: 2005-05-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
Sponsor: Wellstat Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module